| scholarly article | Q13442814 |
| P50 | author | Pere Ginès | Q37841409 |
| Vicente Arroyo | Q41068108 | ||
| Richard Moreau | Q55187617 | ||
| Rajeshwar Mookerjee | Q59259213 | ||
| Rajiv Jalan | Q93336718 | ||
| Jody C Olson | Q99405794 | ||
| Patrick S Kamath | Q114454876 | ||
| P2093 | author name string | Guadalupe Garcia-Tsao | |
| P433 | issue | 6 | |
| P304 | page(s) | 1336-1348 | |
| P577 | publication date | 2012-06-28 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | Acute-on chronic liver failure | |
| P478 | volume | 57 |
| Q48878910 | 'Hepatology' on the move |
| Q89356493 | A Case of Live Donor Liver Transplantation in Acute-on-Chronic Liver Failure with Budd-Chiari Syndrome: Donor and Recipient with Antiphospholipid Antibody Syndrome |
| Q40140446 | A Dynamic Definition of Acute Kidney Injury Does not Improve Prognosis Assessment in Acutely Decompensated Patients with Cirrhosis |
| Q57300686 | A Placebo-Controlled, Multicenter, Double-Blind, Phase 2 Randomized Trial of the Pan-Caspase Inhibitor Emricasan in Patients with Acutely Decompensated Cirrhosis |
| Q28550755 | A Proof of Concept, Phase II Randomized European Trial, on the Efficacy of ALF-5755, a Novel Extracellular Matrix-Targeted Antioxidant in Patients with Acute Liver Diseases |
| Q57488630 | A model predicting short-term mortality in patients with advanced liver cirrhosis and concomitant infection |
| Q102211074 | A prediction model for outcome in patients with HBV-ACLF based on predisposition, injury, response and organ failure |
| Q33638900 | A switch in the source of ATP production and a loss in capacity to perform glycolysis are hallmarks of hepatocyte failure in advance liver disease |
| Q49566604 | AKI persistence at 48 h predicts mortality in patients with acute on chronic liver failure |
| Q48178308 | Aberrant GSTP1 promoter methylation predicts poor prognosis of acute-on-chronic hepatitis B pre-liver failure. |
| Q38608226 | Acute kidney injury in acute on chronic liver failure |
| Q89070690 | Acute on Chronic Liver Failure-In-Hospital Predictors of Mortality in ICU |
| Q38947953 | Acute on chronic liver failure because of acute hepatic insults: Etiologies, course, extrahepatic organ failure and predictors of mortality |
| Q61574792 | Acute-on-Chronic Liver Failure |
| Q36886517 | Acute-on-Chronic Liver Failure (ACLF) in Coastal Eastern India: "A Single-Center Experience". |
| Q56925206 | Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis |
| Q55097285 | Acute-on-Chronic Liver Failure. |
| Q54270858 | Acute-on-Chronic Liver Failure: A Portuguese Single-Center Reference Review |
| Q26823752 | Acute-on-Chronic Liver Failure: Recent Concepts |
| Q26859067 | Acute-on-chronic liver failure |
| Q50956831 | Acute-on-chronic liver failure |
| Q40511289 | Acute-on-chronic liver failure in India: The Indian National Association for Study of the Liver consortium experience |
| Q42695287 | Acute-on-chronic liver failure in a multi-ethnic Asian city: A comparison of patients identified by Asia-Pacific Association for the Study of the Liver and European Association for the Study of the Liver definitions |
| Q47553542 | Acute-on-chronic liver failure in chronic hepatitis B: an update |
| Q46095596 | Acute-on-chronic liver failure in cirrhosis. |
| Q41393577 | Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults |
| Q43740133 | Acute-on-chronic liver failure – Its definition remains unclear |
| Q55652763 | Acute-on-chronic liver failure. |
| Q26851863 | Acute-on-chronic liver failure: A new syndrome that will re-classify cirrhosis |
| Q56925213 | Acute-on-chronic liver failure: Is the definition ready for prime time? |
| Q89623919 | Acute-on-chronic liver failure: Objective admission and support criteria in the intensive care unit |
| Q38635623 | Acute-on-chronic liver failure: Pathogenesis, prognostic factors and management |
| Q26752480 | Acute-on-chronic liver failure: a new syndrome in cirrhosis |
| Q37729728 | Acute-on-chronic liver failure: a review |
| Q40328569 | Acute-on-chronic liver failure: a diagnostic and therapeutic challenge for intensive care |
| Q35707214 | Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014. |
| Q92576301 | Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update |
| Q38698971 | Acute-on-chronic liver failure: recent update |
| Q38720387 | Acute-on-chronic liver failure: terminology, mechanisms and management |
| Q64070081 | Agonist c-Met Monoclonal Antibody Augments the Proliferation of hiPSC-derived Hepatocyte-Like Cells and Improves Cell Transplantation Therapy for Liver Failure in Mice |
| Q52687575 | Alcohol-related acute-on-chronic liver failure-Comparison of various prognostic scores in predicting outcome. |
| Q28084063 | Alcoholic hepatitis and HCV interactions in the modulation of liver disease |
| Q38565782 | Allocation of patients with liver cirrhosis and organ failure to intensive care: Systematic review and a proposal for clinical practice. |
| Q53091033 | Altered frequencies of dendritic cells and IFN-gamma-secreting T cells with granulocyte colony-stimulating factor (G-CSF) therapy in acute-on- chronic liver failure |
| Q35652638 | Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis. |
| Q91235701 | Artificial liver support system therapy in acute-on-chronic hepatitis B liver failure: Classification and regression tree analysis |
| Q37472117 | Ascites' neutrophil function is significantly impaired in patients with decompensated cirrhosis but can be restored by autologous plasma incubation. |
| Q37707450 | Association of Proton Pump Inhibitor Therapy with Hepatic Encephalopathy in Hepatitis B Virus-related Acute-on-Chronic Liver Failure |
| Q48257999 | Autoimmune hepatitis unmasked by nimesulide |
| Q34558638 | Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial. |
| Q52603513 | Bacterial Infection and Predictors of Mortality in Patients with Autoimmune Liver Disease-Associated Acute-On-Chronic Liver Failure. |
| Q26766663 | Bacterial infections in cirrhosis: A critical review and practical guidance |
| Q51018265 | Beyond scoring: a modern interpretation of disease progression in chronic liver disease |
| Q33593368 | Blockade of Neutrophil's Chemokine Receptors CXCR1/2 Abrogate Liver Damage in Acute-on-Chronic Liver Failure |
| Q41712913 | Blood culture-positive infections in patients with alcoholic hepatitis |
| Q97075782 | CLIF-C Organ Failure Score and Liver Volume Predict Prognosis in Steroid-Treated Severe Acute Autoimmune Hepatitis |
| Q41621677 | Case report of acute-on-chronic liver failure secondary to diffuse large B-cell lymphoma |
| Q64104715 | Causes and Consequences of Innate Immune Dysfunction in Cirrhosis |
| Q41986551 | Cell death markers in cirrhotic patients with acute decompensation. |
| Q38763661 | Cell therapy in chronic liver disease |
| Q55110755 | Cellular Mechanisms of Hepatoprotection Mediated by M2-Like Macrophages. |
| Q41677496 | Central nervous system complications after liver transplantation: common but mostly transient phenomena |
| Q36969119 | Changing etiologies and outcome of liver failure in Southwest China |
| Q35943325 | Characterisation of peripheral blood mononuclear cell microRNA in hepatitis B-related acute-on-chronic liver failure |
| Q35898936 | Characteristics and Discrepancies in Acute-on-Chronic Liver Failure: Need for a Unified Definition. |
| Q36747818 | Characteristics and outcomes of chronic liver disease patients with acute deteriorated liver function by severity of underlying liver disease. |
| Q36870839 | Characteristics, Diagnosis and Prognosis of Acute-on-Chronic Liver Failure in Cirrhosis Associated to Hepatitis B. |
| Q38975697 | Characterization of acute-on-chronic liver failure and prediction of mortality in Asian patients with active alcoholism. |
| Q40804882 | Child-Pugh, MELD, and ALBI scores for predicting the in-hospital mortality in cirrhotic patients with acute-on-chronic liver failure |
| Q36098872 | Circulating cell death biomarker: good candidates of prognostic indicator for patients with hepatitis B virus related acute-on-chronic liver failure |
| Q38408871 | Cirrhosis in children and adolescents: An overview. |
| Q38538183 | Cirrhotic Multiorgan Syndrome |
| Q40522443 | Classification and regression tree analysis of acute-on-chronic hepatitis B liver failure: Seeing the forest for the trees. |
| Q41068027 | Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis. |
| Q92360170 | Clinical effectiveness of MARS treatment - multidirectional analysis of positive clinical response to treatment |
| Q36052362 | Clinical effectiveness of cell therapies in patients with chronic liver disease and acute-on-chronic liver failure: a systematic review protocol |
| Q41143087 | Clinical profile, natural history, and predictors of mortality in patients with acute-on-chronic liver failure (ACLF). |
| Q35023406 | Combining serum cystatin C with total bilirubin improves short-term mortality prediction in patients with HBV-related acute-on-chronic liver failure |
| Q36565150 | Comparative transcriptome analysis of peripheral blood mononuclear cells in hepatitis B-related acute-on-chronic liver failure |
| Q35191777 | Comparison of current diagnostic criteria for acute-on-chronic liver failure |
| Q36814499 | Complement Factor 3 Could Be an Independent Risk Factor for Mortality in Patients with HBV Related Acute-on-Chronic Liver Failure |
| Q42219823 | Comprehensive treatment of acute-on-chronic liver failure in a patient with hepatitis B: a case report |
| Q39398214 | Con: Acute-on-Chronic Liver Failure |
| Q45749628 | Correcting thrombocytopenia in patients with liver diseases: A difficult hurdle |
| Q42249705 | Cross-sectional and dynamic change of serum metabolite profiling for Hepatitis B-related acute-on-chronic liver failure by UPLC/MS. |
| Q53072949 | Current Perspectives Regarding Stem Cell-Based Therapy for Liver Cirrhosis |
| Q38820685 | Current challenges and future directions for liver transplantation. |
| Q37440014 | Cystatin C is a biomarker for predicting acute kidney injury in patients with acute-on-chronic liver failure |
| Q37519248 | Dapagliflozin-Induced Acute-on-Chronic Liver Injury |
| Q35602372 | Decreasing mortality among patients hospitalized with cirrhosis in the United States from 2002 through 2010. |
| Q38630335 | Defining acute-on-chronic liver failure: East, West or Middle ground? |
| Q37057161 | Delta-Like Ligand 4 Modulates Liver Damage by Down-Regulating Chemokine Expression |
| Q42051159 | Deregulation of Regulatory T Cells in Acute-on-Chronic Liver Failure: A Rat Model |
| Q40221993 | Differential characteristics and prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure defined by European Association for the Study of the Liver - Chronic Liver Failure criteria |
| Q38432418 | Effectiveness and Safety Assessment of Citrate Anticoagulation During Albumin Dialysis in Comparison to Other Methods of Anticoagulation |
| Q37018854 | Effects of Granulocyte Colony-Stimulating Factor on Patients with Liver Failure: a Meta-Analysis |
| Q64882021 | Elevated Serum IgG Levels Positively Correlated with IL-27 May Indicate Poor Outcome in Patients with HBV-Related Acute-On-Chronic Liver Failure. |
| Q54978475 | Enhancer of zeste homolog 2-catalysed H3K27 trimethylation plays a key role in acute-on-chronic liver failure via TNF-mediated pathway. |
| Q33682905 | Establishment of a new acute-on-chronic liver failure model |
| Q40253424 | Etiology, clinical profile, and inhospital mortality of acute-on-chronic liver failure: a prospective study |
| Q41020332 | Evaluation of neutrophil/leukocyte ratio and organ failure score as predictors of reversibility and survival following an acute-on-chronic liver failure event |
| Q38702799 | Extracorporeal liver support devices for listed patients |
| Q90550033 | Extracorporeal liver support in patients with liver failure: a systematic review and meta-analysis of randomized trials |
| Q38268612 | Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspects |
| Q64973345 | Fibroblast growth factors 19 and 21 in acute liver damage. |
| Q36283332 | First clinical experience in 14 patients treated with ADVOS: a study on feasibility, safety and efficacy of a new type of albumin dialysis |
| Q90656585 | Frequency, characteristics and impact of multiple consecutive nosocomial infections in patients with decompensated liver cirrhosis and ascites |
| Q41108917 | Genomewide Histone H3 Lysine 9 Acetylation Profiling in CD4+ T Cells Revealed Endoplasmic Reticulum Stress Deficiency in Patients with Acute-on-chronic Liver Failure |
| Q26796488 | Genomic Diversity of Hepatitis B Virus Infection Associated With Fulminant Hepatitis B Development |
| Q64111679 | Glucocorticoid Regulates NLRP3 in Acute-On-Chronic Hepatitis B Liver Failure |
| Q38552119 | Growth factors enhance liver regeneration in acute-on-chronic liver failure |
| Q41356741 | Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality |
| Q36076886 | HMGB1/RAGE induces IL-17 expression to exaggerate inflammation in peripheral blood cells of hepatitis B patients |
| Q37226029 | Hemorrhagic Complications Following Abdominal Paracentesis in Acute on Chronic Liver Failure: A Propensity Score Analysis |
| Q39409484 | Hepatic decompensation in the absence of obvious precipitants: the potential role of cytomegalovirus infection/reactivation |
| Q36523843 | Hepatic injury is associated with cell cycle arrest and apoptosis with alteration of cyclin A and D1 in ammonium chloride-induced hyperammonemic rats |
| Q37613156 | Hepatitis E and Acute-on-Chronic Liver Failure |
| Q35188626 | High neutrophil-lymphocyte ratio indicates poor prognosis for acute-on-chronic liver failure after liver transplantation |
| Q44832946 | How can acute-on-chronic liver failure be accurately identified? |
| Q34789475 | Hyponatremia influences the outcome of patients with acute-on-chronic liver failure: an analysis of the CANONIC study |
| Q42282784 | Imbalance between circulating CD4+ regulatory T and conventional T lymphocytes in patients with HBV‐related acute‐on‐chronic liver failure |
| Q38195835 | Immune dysfunction in cirrhosis |
| Q38311148 | Immune mechanisms in acetaminophen-induced acute liver failure |
| Q57494350 | Immunodeficiency caused by cirrhosis |
| Q40385668 | Impact of acute-on-chronic liver failure on 90-day mortality following a first liver transplantation. |
| Q92626545 | Impact of pre-transplant infection management on the outcome of living-donor liver transplantation in Egypt |
| Q36621514 | Improved prescription of taohechengqi-tang alleviates D-galactosamine acute liver failure in rats |
| Q39124195 | Increased delayed mortality in patients with acute-on-chronic liver failure who have prior decompensation |
| Q38797171 | Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease |
| Q57824678 | Intensive Care Therapy for Patients with Advanced Liver Diseases |
| Q33744626 | Interleukin-1 receptor antagonist expression is inversely associated with outcomes of hepatitis B-related acute-on-chronic liver failure |
| Q42247387 | Interleukin-6 upregulates Th17 response via mTOR/STAT3 pathway in acute-on-chronic hepatitis B liver failure |
| Q89178743 | Is Keratin-18 only a Marker of Cell Death in Acute-On-Chronic Liver Failure? |
| Q38199770 | Kidney injury in cirrhosis: pathophysiological and therapeutic aspects of hepatorenal syndromes |
| Q40945062 | LiFe: a liver injury score to predict outcome in critically ill patients |
| Q57824676 | Liver Transplantation in Acute-on-Chronic Liver Failure: Considerations for a Systematic Approach to Decision Making |
| Q38442903 | Liver dialysis in acute-on-chronic liver failure: current and future perspectives. |
| Q52956130 | Liver inflammation abrogates immunological tolerance induced by Kupffer cells |
| Q38544472 | Liver transplantation in acute on chronic liver failure: challenges and an algorithm for patient selection and management. |
| Q43495206 | Liver transplantation in acute-on-chronic liver failure patients with high model for end-stage liver disease (MELD) scores: a single center experience of 100 consecutive cases |
| Q38383408 | Liver transplantation in acute-on-chronic liver failure: lessons learnt from acute liver failure setting |
| Q45002927 | Liver: Acute-on-chronic liver failure--no longer an entity without definition |
| Q89255942 | Mesenchymal Stem Cell/Red Blood Cell-Inspired Nanoparticle Therapy in Mice with Carbon Tetrachloride-Induced Acute Liver Failure |
| Q90087662 | Mesenchymal stem cell therapies for liver cirrhosis: MSCs as "conducting cells" for improvement of liver fibrosis and regeneration |
| Q26771253 | Metabonomic window into hepatitis B virus-related hepatic diseases |
| Q42204812 | Methylation of suppressor of cytokine signalling 1 gene promoter is associated with acute-on-chronic hepatitis B liver failure |
| Q92528066 | MicroRNA profiles in serum samples from Acute-On-Chronic Liver Failure patients and miR-25-3p as a potential biomarker for survival prediction |
| Q40243023 | Model for End-Stage Liver Disease (MELD) score does not predict outcomes of hepatitis B-induced acute-on-chronic liver failure in transplant recipients |
| Q87252765 | Monitoring of intrasplenic hepatocyte transplantation for acute-on-chronic liver failure: a prospective five-year follow-up study |
| Q98386860 | Neutrophil dysfunction predicts 90-day survival in patients with acute on chronic liver failure: A longitudinal case-control study |
| Q58581249 | Next generation sequencing reveals novel alterations in B-cell heavy chain receptor repertoires associated with acute-on-chronic liver failure |
| Q44175960 | Nutrition and liver failure |
| Q56925180 | Organ dysfunctions in patients with alcoholic cirrhosis |
| Q42371761 | Outcome of in- and out-of-hospital cardiac arrest survivors with liver cirrhosis |
| Q92070270 | Outcomes of Liver Transplant Recipients With Acute-on-Chronic Liver Failure Based on EASL-CLIF Consortium Definition: A Single-center Study |
| Q38774754 | Overview on acute-on-chronic liver failure |
| Q39359763 | Patients with HBV-related acute-on-chronic liver failure have increased concentrations of extracellular histones aggravating cellular damage and systemic inflammation |
| Q38504279 | Pattern and profile of chronic liver disease in acute on chronic liver failure |
| Q40245731 | Pentraxin-3 modulates lipopolysaccharide-induced inflammatory response and attenuates liver injury. |
| Q91897717 | Phenotypic switch of human and mouse macrophages and resultant effects on apoptosis resistance in hepatocytes |
| Q34071897 | Plasma Interleukin-10: A Likely Predictive Marker for Hepatitis B Virus-Related Acute-on-Chronic Liver Failure |
| Q40821445 | Plasma interleukin-10 predicts short-term mortality of acute-on-chronic hepatitis B liver failure |
| Q39206078 | Plasma von Willebrand factor levels predict in-hospital survival in patients with acute-on-chronic liver failure |
| Q90352014 | Plasminogen as a prognostic biomarker for HBV-related acute-on-chronic liver failure |
| Q37162349 | Population-representative Incidence of Acute-On-Chronic Liver Failure: A Prospective Cross-Sectional Study |
| Q38779827 | Preconditioning methods in the management of hepatic ischemia reperfusion- induced injury: Update on molecular and future perspectives |
| Q44625647 | Predictive factors of organ failure in patients admitted in intensive care unit for acute gastrointestinal bleeding |
| Q92679696 | Predictive value of the Chinese group on the study of severe hepatitis B-acute-on-chronic liver failure score in the short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure |
| Q41387562 | Predictors of mortality among patients with compensated and decompensated liver cirrhosis: the role of bacterial infections and infection-related acute-on-chronic liver failure |
| Q36151739 | Predictors of mortality within 6 weeks after treatment of gastric variceal bleeding in cirrhotic patients |
| Q40668732 | Predictors of progression into acute-on-chronic liver failure from acute deterioration of pre-existing chronic liver disease |
| Q37482912 | Prevalence and risk factors of acute-on-chronic liver failure in a single center from Argentina |
| Q87012157 | Prioritization of the cirrhotic patients entering intensive care unit for liver transplantation: Do we need to change the rules? |
| Q47151360 | Prognostic factors of the short-term outcomes of patients with hepatitis B virus-associated acute-on-chronic liver failure |
| Q36348416 | Prognostic impact of ICG-PDR in patients with hypoxic hepatitis |
| Q36741816 | Prognostic performance of clinical indices and model scorings for acute-on-chronic liver failure: A study of 164 patients |
| Q44398396 | Prognostic scores for cirrhotic patients admitted to an intensive care unit: Which consequences for liver transplantation? |
| Q37617999 | Prognostic value of M30/M65 for outcome of hepatitis B virus-related acute-on-chronic liver failure |
| Q86203214 | Prostaglandin E2 -mediated immunosuppression and the role of albumin as its modulator |
| Q36131807 | Reduced cortical thickness in patients with acute-on-chronic liver failure due to non-alcoholic etiology |
| Q38632428 | Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure. |
| Q37009273 | Restoring the Treg cell to Th17 cell ratio may alleviate HBV-related acute-on-chronic liver failure |
| Q98289270 | Review of Serum Biomarkers and Models Derived from Them in HBV-Related Liver Diseases |
| Q30243874 | Reviewing the diagnostic criteria for acute-on-chronic liver failure |
| Q40707123 | Risk stratification of decompensated cirrhosis patients by Chronic Liver Failure Consortium scores: Classification and regression tree analysis |
| Q38888375 | Role of ammonia, inflammation, and cerebral oxygenation in brain dysfunction of acute-on-chronic liver failure patients |
| Q42042373 | Role of systemic inflammation in cirrhosis: From pathogenesis to prognosis |
| Q35957918 | SDF-1/CXCR4 Axis Promotes MSCs to Repair Liver Injury Partially through Trans-Differentiation and Fusion with Hepatocytes |
| Q41744721 | Scoring systems for 6-month mortality in critically ill cirrhotic patients: a prospective analysis of chronic liver failure - sequential organ failure assessment score (CLIF-SOFA). |
| Q34172324 | Scoring systems for predicting mortality after liver transplantation |
| Q38206836 | Scoring systems predict the prognosis of acute-on-chronic hepatitis B liver failure: an evidence-based review |
| Q30358956 | Serum Glycopatterns as Novel Potential Biomarkers for Diagnosis of Acute-on-Chronic Hepatitis B Liver Failure |
| Q39602278 | Serum bile acids as marker for acute decompensation and acute-on-chronic liver failure in patients with non-cholestatic cirrhosis |
| Q38851740 | Serum soluble ST2 is a promising prognostic biomarker in HBV-related acute-on-chronic liver failure. |
| Q34066622 | Serum sphingolipids reflect the severity of chronic HBV infection and predict the mortality of HBV-acute-on-chronic liver failure |
| Q35082871 | Serum testosterone levels and androgen receptor CAG polymorphism correlate with hepatitis B virus (HBV)-related acute liver failure in male HBV carriers |
| Q42180989 | Serum wnt5a is a predictor for the prognosis of acute on chronic hepatitis B liver failure. |
| Q50279590 | Single center validation of mortality scores in patients with acute decompensation of cirrhosis with and without acute-on-chronic liver failure |
| Q37417325 | Sonoclot signature analysis in patients with liver disease and its correlation with conventional coagulation studies |
| Q41542341 | Sorafenib-induced acute-on-chronic liver failure in a patient with hepatocellular carcinoma after transarterial chemoembolization and radiofrequency ablation: A case report |
| Q38685234 | Substantial hepatic necrosis is prognostic in fulminant liver failure |
| Q33831448 | Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures |
| Q35995445 | Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis. |
| Q45323617 | TLR2 Expression in Peripheral CD4+ T Cells Promotes Th17 Response and Is Associated with Disease Aggravation of Hepatitis B Virus-Related Acute-On-Chronic Liver Failure |
| Q34861969 | Targeting the gut-liver axis in cirrhosis: antibiotics and non-selective β-blockers. |
| Q37328532 | The Clinical Course of Cirrhosis Patients Hospitalized for Acute Hepatic Deterioration: A Prospective Bicentric Study |
| Q36901892 | The global burden of liver disease: the major impact of China |
| Q59329727 | Therapeutic efficiency of human amniotic epithelial stem cell-derived functional hepatocyte-like cells in mice with acute hepatic failure |
| Q52653082 | Thymosin α1 treatment reduces hepatic inflammation and inhibits hepatocyte apoptosis in rats with acute liver failure |
| Q38542046 | Two sides of one coin: massive hepatic necrosis and progenitor cell-mediated regeneration in acute liver failure |
| Q40508722 | Up-regulation of A20 gene expression in peripheral blood mononuclear cells is associated with acute-on-chronic hepatitis B liver failure |
| Q36196002 | Upregulated Expression of A20 on Monocytes is Associated With Increased Severity of Acute-on-Chronic Hepatitis B Liver Failure: A Case-Control Study |
| Q37510598 | Use of the delta neutrophil index as a prognostic factor of mortality in patients with spontaneous bacterial peritonitis: implications of a simple and useful marker. |
| Q57283359 | Validation of CLIF-C ACLF score to define a threshold for futility of intensive care support for patients with acute-on-chronic liver failure |
| Q33627295 | Validation of prognostic scores to predict short-term mortality in patients with HBV-related acute-on-chronic liver failure: The CLIF-C OF is superior to MELD, CLIF SOFA, and CLIF-C ACLF |
| Q91768458 | Validation of the prognostic models in acute-on-chronic liver failure precipitated by hepatic and extrahepatic insults |
| Q49529586 | Value of the albumin-bilirubin score in the evaluation of hepatitis B virus-related acute-on-chronic liver failure, liver cirrhosis, and hepatocellular carcinoma |
| Q59357160 | [Long-term prognosis and quality of life of survivors with hepatitis B virus-related acute-on-chronic liver failure] |
Search more.